Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human GCDH Protein, N-His

Catalog #:   YHJ34901 Specific References (49) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q92947
Protein length: Glu270-Lys438
Overview

Catalog No.

YHJ34901

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Glu270-Lys438

Predicted molecular weight

20.66 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q92947

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Glutaryl-CoA dehydrogenase, mitochondrial, GCD, GCDH

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human GCDH protein
References

Glutaric aciduria type-1 in a teenager with nutritional vitamin B12 deficiency: coexistence of two treatable conditions., PMID:40280570

Impairment of neuromotor development and cognition associated with histopathological and neurochemical abnormalities in the cerebral cortex and striatum of glutaryl-CoA dehydrogenase deficient mice., PMID:39522695

Genetic Polymorphisms Associated with Fetal Hemoglobin (HbF) Levels and F-Cell Numbers: A Systematic Review of Genome-Wide Association Studies., PMID:39518961

Rewiring Lysine Catabolism in Cancer Leads to Increased Histone Crotonylation and Immune Escape., PMID:39462882

Use of the Novel Site-Directed Enzyme Enhancement Therapy (SEE-Tx) Drug Discovery Platform to Identify Pharmacological Chaperones for Glutaric Acidemia Type 1., PMID:39312412

Preserving mitochondrial homeostasis protects against drug-induced liver injury via inducing OPTN (optineurin)-dependent Mitophagy., PMID:39099169

Investigating the causal association between obesity and risk of hepatocellular carcinoma and underlying mechanisms., PMID:38977823

Glutaryl-CoA dehydrogenase suppresses tumor progression and shapes an anti-tumor microenvironment in hepatocellular carcinoma., PMID:38825017

Expression of cellobiose dehydrogenase gene in Aspergillus niger C112 and its effect on lignocellulose degrading enzymes., PMID:38562472

Compilation of Genotype and Phenotype Data in GCDH-LOVD for Variant Classification and Further Application., PMID:38137040

Spatiotemporal Modulated Scaffold for Endogenous Bone Regeneration via Harnessing Sequentially Released Guiding Signals., PMID:38058149

Glutaryl-CoA Dehydrogenase Misfolding in Glutaric Acidemia Type 1., PMID:37685964

High genetic heterogeneity of leukodystrophies in Iranian children: the first report of Iranian Leukodystrophy Registry., PMID:37597066

Analysis of lactate metabolism-related genes and their association with immune infiltration in septic shock via bioinformatics method., PMID:37564869

Glutaric aciduria and L-2-hydroxyglutaric aciduria: Clinical and molecular findings of 35 patients from Turkey., PMID:37275239

Lysine catabolism reprograms tumour immunity through histone crotonylation., PMID:37198486

Phenotypic prediction in glutaric aciduria type 1 combining in silico and in vitro modeling with real-world data., PMID:37078465

Exploring genotype-phenotype correlations in glutaric aciduria type 1., PMID:37020324

Proteomic analysis revealed the pharmacological mechanism of Xueshuantong injection in preventing early acute myocardial infarction injury., PMID:36618918

Metabolic patterns in brain 18F-fluorodeoxyglucose PET relate to aetiology in paediatric dystonia., PMID:36445406

Treatment of glutaric aciduria type I (GA-I) via intracerebroventricular delivery of GCDH., PMID:38933374

NRF2 mediates melanoma addiction to GCDH by modulating apoptotic signalling., PMID:36050469

Development of hetero-triaryls as a new chemotype for subtype-selective and potent Sirt5 inhibition., PMID:35853430

Disturbance of Mitochondrial Dynamics, Endoplasmic Reticulum-Mitochondria Crosstalk, Redox Homeostasis, and Inflammatory Response in the Brain of Glutaryl-CoA Dehydrogenase-Deficient Mice: Neuroprotective Effects of Bezafibrate., PMID:35639256

[Identification of onco-miRNAs in hepatocellular carcinoma and analysis of their regulatory network]., PMID:35249869

Deglutarylation of glutaryl-CoA dehydrogenase by deacylating enzyme SIRT5 promotes lysine oxidation in mice., PMID:35157847

A knock-in rat model unravels acute and chronic renal toxicity in glutaric aciduria type I., PMID:34799272

Clinical Characteristics, Molecular Profile, and Outcomes in Indian Patients with Glutaric Aciduria Type 1., PMID:34504725

Biochemical and molecular features of Chinese patients with glutaric acidemia type 1 detected through newborn screening., PMID:34344405

Protective effects of L-carnitine on behavioral alterations and neuroinflammation in striatum of glutaryl-COA dehydrogenase deficient mice., PMID:34181873

Dysregulated Provision of Oxidisable Substrates to the Mitochondria in ME/CFS Lymphoblasts., PMID:33669532

Glutaric acidemia type 1: Treatment and outcome of 168 patients over three decades., PMID:33069577

Lipopolysaccharide-Elicited Systemic Inflammation Induces Selective Vulnerability of Cerebral Cortex and Striatum of Developing Glutaryl-CoA Dehydrogenase Deficient (Gcdh-/-) Mice to Oxidative Stress., PMID:33001399

Functional Recovery of a GCDH Variant Associated to Severe Deflavinylation-Molecular Insights into Potential Beneficial Effects of Riboflavin Supplementation in Glutaric Aciduria-Type I Patients., PMID:32992790

Assessment of candidate variants causative of inborn metabolic diseases in SUDI cases in South Africa, and a case report., PMID:32556492

Molecular and biochemical study of glutaric aciduria type 1 in 49 Russian families: nine novel mutations in the GCDH gene., PMID:32240488

FOLFOX treatment response prediction in metastatic or recurrent colorectal cancer patients via machine learning algorithms., PMID:31893575

Characterization of novel GCDH pathogenic variants causing glutaric aciduria type 1 in the southeast of Mexico., PMID:31788423

Potential complementation effects of two disease-associated mutations in tetrameric glutaryl-CoA dehydrogenase is due to inter subunit stability-activity counterbalance., PMID:31491587

Regulation of Glutarate Catabolism by GntR Family Regulator CsiR and LysR Family Regulator GcdR in Pseudomonas putida KT2440., PMID:31363033

l-Carnitine prevents oxidative stress in striatum of glutaryl-CoA dehydrogenase deficient mice submitted to lysine overload., PMID:31181292

Acute lysine overload provokes marked striatum injury involving oxidative stress signaling pathways in glutaryl-CoA dehydrogenase deficient mice., PMID:31121257

Ammonium accumulation and chemokine decrease in culture media of Gcdh-/- 3D reaggregated brain cell cultures., PMID:30686684

[Clinical and variation analysis of three Chinese families affected with glutaric acidemia type 1]., PMID:30512148

Disease-Linked Glutarylation Impairs Function and Interactions of Mitochondrial Proteins and Contributes to Mitochondrial Heterogeneity., PMID:30208319

Molecular genetic study of glutaric aciduria, type I: Identification of a novel mutation., PMID:30203563

Long Lasting High Lysine Diet Aggravates White Matter Injury in Glutaryl-CoA Dehydrogenase Deficient (Gcdh-/-) Mice., PMID:29779173

Two Uneventful Pregnancies in a Woman with Glutaric Aciduria Type 1., PMID:29292490

Induction of Neuroinflammatory Response and Histopathological Alterations Caused by Quinolinic Acid Administration in the Striatum of Glutaryl-CoA Dehydrogenase Deficient Mice., PMID:29235064

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human GCDH Protein, N-His [YHJ34901]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only